What is the equivalent dose of methadone for OxyContin (oxycodone) ER?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oxycodone ER to Methadone Conversion

When converting from OxyContin ER (oxycodone extended-release) to methadone, use a conversion ratio of approximately 3:1 (3 mg of oxycodone equals 1 mg of methadone) for most patients, but this ratio varies based on the total daily oxycodone dose. 1

Conversion Process

The conversion from oxycodone ER to methadone requires careful consideration due to methadone's unique pharmacological properties:

  1. Calculate total daily oxycodone dose

    • Add up all oxycodone doses taken in 24 hours
  2. Apply appropriate conversion ratio based on total daily dose:

    • For lower doses of oxycodone: use 3:1 ratio 1
    • For higher doses (>300 mg/day): consider higher ratios (4:1 or greater) 2
  3. Reduce calculated methadone dose by 25-50% to account for incomplete cross-tolerance 2

  4. Divide total daily methadone dose into 3-4 doses per day initially 2

Example Calculation

For a patient taking 60 mg of OxyContin ER daily:

  • Total daily oxycodone dose: 60 mg
  • Apply 3:1 conversion ratio: 60 ÷ 3 = 20 mg methadone
  • Reduce by 25-50% for safety: 10-15 mg methadone daily
  • Divide into 3 doses: approximately 3-5 mg methadone every 8 hours

Important Considerations

Methadone's Unique Properties

  • Long and variable half-life (15-60 hours) with potential for accumulation 2
  • Delayed peak respiratory depression occurring later than peak analgesic effect 2
  • QTc prolongation risk, especially at doses >100 mg/day 2
  • Unpredictable individual response due to complex pharmacokinetics 2

Safety Precautions

  • Start with lower doses than calculated and titrate gradually
  • Monitor closely during the first week of conversion due to risk of accumulation
  • Consider ECG monitoring for patients with cardiac risk factors or doses >100 mg/day 2
  • Avoid rapid titration - methadone dose increases should occur no more frequently than every 5-7 days 2

Risk Factors

  • High-dose conversions carry greater risk of overdose
  • Elderly patients may require lower doses
  • Renal/hepatic dysfunction may require dose adjustment
  • Drug interactions are common with methadone (particularly medications affecting QTc interval) 2

CDC Morphine Milligram Equivalent (MME) Considerations

For reference, the CDC provides these conversion factors to calculate MMEs 2:

  • Oxycodone: 1.5 (multiply dose by 1.5 to get MME)
  • Methadone: 4.7 (multiply dose by 4.7 to get MME)

However, methadone's conversion factor varies by dose 2:

  • 1-20 mg/day: factor of 4
  • 21-40 mg/day: factor of 8
  • 41-60 mg/day: factor of 10
  • ≥61-80 mg/day: factor of 12

Monitoring After Conversion

  • Assess pain control and side effects daily for first week
  • Watch for signs of oversedation or respiratory depression
  • Be prepared to adjust dosing based on clinical response
  • Provide rescue doses of immediate-release opioid if needed during transition

Common Pitfalls to Avoid

  • Using fixed conversion ratios without considering total daily dose
  • Failing to reduce calculated dose to account for incomplete cross-tolerance
  • Titrating methadone too quickly (accumulation may not be apparent for days)
  • Not monitoring for cardiac effects in at-risk patients
  • Converting directly to twice-daily dosing (start with more frequent dosing initially)

Remember that methadone should not be the first choice for an extended-release opioid due to its complex pharmacokinetics and potential for serious adverse effects 2.

References

Research

Switching from oxycodone to methadone in advanced cancer patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.